Literature DB >> 21362379

Semi-mature MyD88-silenced bone marrow dendritic cells prolong the allograft survival in a rat model of intestinal transplantation.

Xiao-Jun Yang1, Song Meng, Chun-Fu Zhu, Hong Jiang, Wen-Xi Wu.   

Abstract

BACKGROUND: Semi-mature dendritic cells (DCs) may induce tolerance rather than immunity. However, little is known about the regulatory mechanism by which these DCs induce transplant tolerance. Myeloid differentiation factor 88 (MyD88) is a key adaptor of Toll-like receptor signaling, which plays a critical role in DC maturation. Activation of MyD88-silenced immature DCs results in the generation of semi-mature DCs. We explored the possibility of using these DCs to induce intestinal transplant tolerance in rats.
METHODS: MyD88 expression was silenced in bone marrow DCs (F344 rats) using small interfering RNAs for 24 hours, at which point, lipopolysaccharide (LPS) was added to the culture for another 48 hours. These cells were analyzed for their in vitro and in vivo tolerizing capacities.
RESULTS: Semi-mature DCs expressing moderate levels of MHC class II and low levels of co-stimulatory molecules were found to produce interleukin (IL)-10, while IL-12 production was decreased. In vitro co-culture with completely allogeneic T cells from Wistar rats led to a significant decrease in alloreactive T-cell responses. In vivo, the transfer of semi-mature DCs (1 × 10(6) cells) followed by the transplantation of fully mismatched intestinal grafts (F344 rats) led to significantly prolonged survival compared to rats receiving immature and mature DCs. Serum from semi-mature DC-treated rats contained lower concentrations of the pro-inflammatory cytokines IL-2 and interferon-γ 5 days after transplantation.
CONCLUSION: Semi-mature DCs may promote inducible allograft tolerance and this study suggests a new strategy by which to facilitate the induction of transplant tolerance.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21362379

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  5 in total

Review 1.  Dendritic Cells and Their Immunotherapeutic Potential for Treating Type 1 Diabetes.

Authors:  Farhan Ullah Khan; Puregmaa Khongorzul; Ahmed Aziz Raki; Ashwini Rajasekaran; Denis Gris; Abdelaziz Amrani
Journal:  Int J Mol Sci       Date:  2022-04-28       Impact factor: 6.208

2.  PU.1-silenced dendritic cells prolong allograft survival in rats receiving intestinal transplantation.

Authors:  Xing-Wei Xu; Bo-Wen Ding; Chuan-Rong Zhu; Wu Ji; Jie-Shou Li
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

3.  Therapeutic potential of semi-mature dendritic cells for tolerance induction.

Authors:  Manfred B Lutz
Journal:  Front Immunol       Date:  2012-05-18       Impact factor: 7.561

Review 4.  Metabolism Is Central to Tolerogenic Dendritic Cell Function.

Authors:  Wen Jing Sim; Patricia Jennifer Ahl; John Edward Connolly
Journal:  Mediators Inflamm       Date:  2016-02-11       Impact factor: 4.711

Review 5.  Effects of Adoptive Transfer of Tolerogenic Dendritic Cells on Allograft Survival in Organ Transplantation Models: An Overview of Systematic Reviews.

Authors:  Yanni Zhou; Juan Shan; Yingjia Guo; Shengfu Li; Dan Long; Youping Li; Li Feng
Journal:  J Immunol Res       Date:  2016-07-28       Impact factor: 4.818

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.